Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available to corporate clients. The cloud-based Strategic Intellectual Property Insight Platform “uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.” As a byproduct of this project, I.B.M. is contributing their research to the searchable NIH chemical database, which will ease access to information previously mired in paperwork.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
Tagsbiofuel biotech industry Biofuel Technology Events healthcare renewable fuel standard FDA agriculture Partnering greenhouse gas emissions BIO Events One-on-One's Health Care Greenhouse Gas Emission business development BIO International Convention BIOTECH health vaccines climate change
- Most Popular
Latest VideoHans Schikan, CEO of Prosensa, on Rare Disease Drug Development View All >